Related Experiment Videos
TIP30 deficiency increases susceptibility to tumorigenesis
Mitsuhiro Ito1, Chao Jiang, Kristy Krumm
1Laboratory of Biochemistry and Molecular Biology, The Rockefeller University, New York, New York, USA.
Cancer Research
|December 26, 2003
Summary
The tumor suppressor TIP30 (also known as CC3 or Htatip2) is crucial for preventing cancer. Loss of TIP30 function leads to increased tumor development, particularly hepatocellular carcinoma, highlighting its role in tumor suppression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- TIP30 (CC3/Htatip2) is a potential metastasis suppressor, promoting apoptosis and inhibiting angiogenesis.
- In vitro studies suggest TIP30 acts as a tumor suppressor, but in vivo evidence and human cancer associations were lacking.
Purpose of the Study:
- To investigate the in vivo role of TIP30 in tumor development.
- To determine if TIP30 deficiency contributes to cancer susceptibility.
- To assess TIP30 expression and mutation status in human hepatocellular carcinoma.
Main Methods:
- Utilized genetically engineered mice and TIP30-deficient cells.
- Performed in vivo tumor incidence studies.
- Conducted immunohistochemical analysis and gene sequencing on human hepatocellular carcinoma samples.
Main Results:
- TIP30-deficient mice exhibited a high incidence of hepatocellular carcinoma and other tumors.
- Loss of TIP30 increased fibroblast susceptibility to SV40 large T antigen-induced transformation.
- Reduced TIP30 expression was observed in 33% of human hepatocellular carcinomas, with some harboring mutations.
Conclusions:
- The Tip30 gene functions as a tumor susceptibility gene.
- TIP30 plays a significant role in suppressing hepatocarcinogenesis.
- Loss or mutation of TIP30 contributes to human liver cancer development.